Recruitment
PulseSight Therapeutics closes Series A financing for dry AMD phase 1 clinical study
February 14, 2025 Clinical Research Opthalmology, age-related macular degeneration, clinical trials
Ophthalmology biotech PulseSight Therapeutics has confirmed the closure of its Series A funding round, the proceeds of which will be …
Results from Novadip phase 1b/2a trial reveal 88% efficacy
January 28, 2025 Clinical Research Congenital Pseudoarthritis of the Tibia, Rare Diseases, clinical trials, efficacy, paediatric, rare diseases
Novadip Biosciences, a clinical stage biotechnology company with a specialty in regenerative medicine, has announced the results of its 12-month …
China CDE clears Phase 3 Study of Lisafltoclax in Newlly Diagnosed Patients with Higher-Risk Myelodysplastic Syndrome
August 13, 2024 Clinical Research, Research and Development Ascentage Pharma, Oncology
The China Centre for Drug Evaluation (CDE) has cleared the registrational phase 3 study of lisaftoclax in combination with azacitadine …
Drug discovery and development partnership announced between Apollo Therapeutics and Oxford University
July 31, 2024 Clinical Research, Medical Communications, Research and Development Apollo Therapeutics, Internal Medicine, Microbiology, drug development, drug discovery, research
Portfolio therapeutics company Apollo Therapeutics has announced earlier this week that it will provide capital and expertise to Oxford University’s …
Astellas set to open new life sciences facilities in Cambridge, Massachusetts
August 10, 2023 Business Development Astellas Pharma, Pharmacy, pharmaceutical, science facility
On 9 August 2023, Astellas Pharma announced its plans to open what it has described as a “state-of-the-art life sciences …
Latest content
The evidence bar impacting UK medical cannabis access
November 6, 2026
Addressing the rheumatic disease diagnostic gap in primary care
November 5, 2026
